Getting advanced cancer treatments to patients faster matters. FDA Fast Track for "off-the-shelf" CAR T (engineered immune cells from donors) for aggressive blood cancers. Personalized CAR T takes weeks.
Imugene's azer-cel, an "off-the-shelf" CAR T-cell therapy, has been granted FDA Fast Track Designation for relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and
